Lombard Medical exhibits Aorfix system at Critical Issues in Aortic Endografting symposium

Published on June 30, 2014 at 9:19 AM · No Comments

Lombard Medical, Inc (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), exhibited its Aorfix Endovascular stent graft system at the 18th international experts' symposium, Critical Issues in Aortic Endografting, in Malmö, Sweden on June 27-28, 2014.

Aorfix, which was formally launched in the US last November, is the only AAA stent graft approved by the FDA for the treatment of patients with aortic aneurysm neck angulations up to 90 degrees providing an 'on-label' EVAR treatment option for US patients with tortuous AAA anatomy for the first time.

CEO Simon Hubbert stated, "Critical Issues in Aortic Endografting is one of the year's most important symposia for clinicians in the EVAR field. We were encouraged by the high level of awareness of Aorfix and its increasing use in hospitals around the world. The global community of physicians that now recognize there is a safe, effective and FDA-approved solution to treating the underserved patient population with highly angulated AAAs is clearly expanding. We are confident that this trend will continue, underpinned by the strong support of both key opinion leaders at academic centers and community practitioners."

Critical Issues in Aortic Endografting is a pre-eminent global forum where world-renowned clinicians convene to discuss and debate the latest technologies, techniques and issues in aortic endograft treatment.

Dr. John Hardman (Bath, UK) presented a paper at the symposium on Friday, June 27 entitled "Neck angulation is not an issue - proper device selection." In this paper he demonstrated that with the correct choice of stent grafts, even challenging anatomies, can have successful EVAR outcomes. Dr. Hardman specifically cited Aorfix as the stent graft of choice when presented with challenging AAA anatomies.

Dr. Nilo Mosquera (Ourense, Spain) also presented his experiences and results with the Aorfix Endovascular stent graft. Dr. Mosquera concluded that "Aorfix provides a safe and effective EVAR solution for patients with challenging anatomy within the IFU indications (0-90º neck angulations)."

Source:

Lombard Medical, Inc.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Zilver® PTX® drug-eluting stent from Cook Medical receives positive one-year follow-up results